Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome
Marie Sébert, Emmanuelle Clappier, Sylvie Chevret, Hugo Bergugnat et autres
0 citationsLeukemia
Thomas Cluzeau
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
517Publications signalées
7853Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell Transplantation
Publications récentes
Selenoproteins in myeloid lineage and acute myeloid leukemia: targeting new vulnerabilities a narrative minireview
Adele Rivault, Coline Savy, Cécile Favreau, Thomas Cluzeau et autres
0 citationsCellular & Molecular Biology Letters
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone—a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT
Joanna Drozd‐Sokołowska, Patrick Gilbert, Joe Tuffnell, Linda Koster et autres
0 citationsBone Marrow Transplantation
Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort
Lin‐Pierre Zhao, Céline Berthon, Laurène Fenwarth, Stéphane de Botton et autres
0 citationsLeukemia
POSTER: MDS-838: Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
Rami Komrokji, Maria Diez Campelo, Shuh Ying Tan, David Valcarcel Ferreiras et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: MDS-824: Elritercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent–Naïve Adults With Lower-Risk Myelodysplastic Syndromes and Transfusion-Dependent Anemia: The Elrise MDS Phase 3 Study
Valeria Santini, Rami Komrokji, Guillermo Garcia-Manero, Hetty E Carraway et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
MDS-824: Elritercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent–Naïve Adults With Lower-Risk Myelodysplastic Syndromes and Transfusion-Dependent Anemia: The Elrise MDS Phase 3 Study
Valeria Santini, Rami Komrokji, Guillermo Garcia-Manero, Hetty E Carraway et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
MDS-838: Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
Rami Komrokji, Maria Diez Campelo, Shuh Ying Tan, David Valcarcel Ferreiras et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Tamibarotene with Venetoclax and Azacitidine in RARA-Positive Acute Myeloid Leukemia: Results from the SY-1425-202 Study
Thomas Cluzeau, Uma Borate, Christine M. McMahon, Pierre Fenaux et autres
0 citationsBlood Neoplasia
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML
Laurène Fenwarth, Loïc Vasseur, Nicolas Duployez, Augustin Boudry et autres
0 citationsBlood Cancer Journal
Supplementary Figure 1 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, David A. Sallman et autres
0 citations
Supplementary Figure 7 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, David A. Sallman et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.